BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 6, 2025
Home
»
Authors
»
Aaron Lorenzo
Articles by Aaron Lorenzo
Neurocrine, Valentis Dropping Staff In Wake Of Drug Failures
Aug. 9, 2006
By
Aaron Lorenzo
Neurocrine, Valentis Dropping Staff In Wake Of Drug Failures
Aug. 9, 2006
By
Aaron Lorenzo
New Analysis Shows ESC State Funding Not Enough
Aug. 8, 2006
By
Aaron Lorenzo
BioCryst, FDA Agree On SPA For Fodosine In Blood Cancer
Aug. 8, 2006
By
Aaron Lorenzo
BioCryst, FDA Agree On SPA For Fodosine In Blood Cancer
Aug. 8, 2006
By
Aaron Lorenzo
New Analysis Shows ESC State Funding Not Enough
Aug. 8, 2006
By
Aaron Lorenzo
Osiris' IPO Generates $38.5M For Adult Stem Cell Products
Aug. 7, 2006
By
Aaron Lorenzo
Osiris' IPO Generates $38.5M For Adult Stem Cell Products
Aug. 7, 2006
By
Aaron Lorenzo
FDA Clears Vaccines For Coming Influenza Season
Aug. 4, 2006
By
Aaron Lorenzo
FDA Clears Vaccines For Coming Influenza Season
Aug. 4, 2006
By
Aaron Lorenzo
Previous
1
2
…
37
38
39
40
41
42
43
44
45
…
237
238
Next
